(Q61957273)
Statements
A Phase I Study of a Combination of the Proteosome Proliferator-Activated Receptor Gamma Agonist, CS-7017 and the Retinoid X Receptor Agonist, Bexarotene (English)
0 references
December 2011
0 references
December 2016
0 references
9
0 references
18 year
0 references